Antonio Jiménez‐Velasco
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 25
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 6
- Cancer Research top 5%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 12
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 11
- Cancer-related gene regulation 8
- Transplantation top 10%
-
- Eosinophilic Disorders and Syndromes 10
-
- Acute Lymphoblastic Leukemia research 7
- Co-authors
- José Román‐GómezAnabel HeinigerXabier AgirreFelipe PrósperAntónio TorresLeire GárateLucía CordeuEdurne San José‐Eneriz
- Cited by
- HematologyCancer ResearchGenetics
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Antonio Jiménez‐Velasco
52 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Hematology 713
- Cancer Research 573
- Genetics 332
- Molecular Biology 1.1k
- Transplantation 39
Countries citing papers authored by Antonio Jiménez‐Velasco
This map shows the geographic impact of Antonio Jiménez‐Velasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Jiménez‐Velasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Jiménez‐Velasco more than expected).
Fields of papers citing papers by Antonio Jiménez‐Velasco
This network shows the impact of papers produced by Antonio Jiménez‐Velasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Jiménez‐Velasco. The network helps show where Antonio Jiménez‐Velasco may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Antonio Jiménez‐Velasco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 7 | |
| 2 | 2019 | 97 | |
| 3 | 2019 | 29 | |
| 4 | 2017 | 4 | |
| 5 | 2017 | 4 | |
| 6 | 2016 | 28 | |
| 7 | 2012 | 6 | |
| 8 | 2009 | 242 | |
| 9 | 2009 | 69 | |
| 10 | 2009 | 20 | |
| 11 | 2009 | 97 | |
| 12 | 2008 | 173 | |
| 13 | 2008 | 33 | |
| 14 | 2008 | 28 | |
| 15 | 2008 | 31 | |
| 16 | 2007 | 52 | |
| 17 | 2007 | 65 | |
| 18 | 2005 | 10 | |
| 19 | 2005 | 76 | |
| 20 | 2005 | 56 |
About Antonio Jiménez‐Velasco
Antonio Jiménez‐Velasco is a scholar working on Hematology, Genetics and Rheumatology, having authored 52 papers that have together received 1.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (12 papers), Epigenetics and DNA Methylation (11 papers), Eosinophilic Disorders and Syndromes (10 papers), Cancer-related gene regulation (8 papers), Hematopoietic Stem Cell Transplantation (8 papers), Acute Lymphoblastic Leukemia research (7 papers) and Acute Myeloid Leukemia Research (6 papers). The work is most often cited by research in Hematology (713 citations), Cancer Research (573 citations) and Genetics (332 citations). Antonio Jiménez‐Velasco has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include José Román‐Gómez, Anabel Heiniger, Xabier Agirre, Felipe Prósper, António Torres, Leire Gárate, Lucía Cordeu, Edurne San José‐Eneriz, Marı́a José Calasanz and Amaia Vilas‐Zornoza. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.